Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes

por Herold, Zoltan, Herold, Magdolna, Lohinszky, Julia, Dank, Magdolna, Somogyi, Aniko
Publicado 2020

Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer

por Herold, Zoltan, Herold, Magdolna, Lohinszky, Julia, Szasz, Attila Marcell, Dank, Magdolna, Somogyi, Aniko
Publicado 2022

Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients

por Kleef, Ralf, Dank, Magdolna, Herold, Magdolna, Agoston, Emese Irma, Lohinszky, Julia, Martinek, Emoke, Herold, Zoltan, Szasz, Attila Marcell
Publicado 2023

Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case series

por Tőke, Judit, Uhlyarik, Andrea, Lohinszky, Júlia, Stark, Júlia, Huszty, Gergely, Micsik, Tamás, Borka, Katalin, Reismann, Péter, Horányi, János, Igaz, Peter, Tóth, Miklós
Publicado 2022